世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Viral Pneumonia Treatment Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5025 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ウイルス性肺炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リバビリン、アシクロビル、ガンシクロビル、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ウイルス性肺炎治療薬の市場動向 ・企業の競争状況、市場シェア ・ウイルス性肺炎治療薬の種類別市場規模と予測2016-2027（リバビリン、アシクロビル、ガンシクロビル、その他） ・ウイルス性肺炎治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、その他） ・ウイルス性肺炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ウイルス性肺炎治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ウイルス性肺炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ウイルス性肺炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ウイルス性肺炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、GlaxoSmithKline、Pfizer、Novartis、Johnson and Johnson、Teva Pharmaceutical） ・結論

Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market
The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Pneumonia Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Pneumonia Treatment Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Pneumonia Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Pneumonia Treatment Drugs market.

Global Viral Pneumonia Treatment Drugs Scope and Market Size
Viral Pneumonia Treatment Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Viral Pneumonia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Ribavirin
Acyclovir
Ganciclovir
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
GlaxoSmithKline
Pfizer
Novartis
Johnson and Johnson
Teva Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Pneumonia Treatment Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ribavirin
1.2.3 Acyclovir
1.2.4 Ganciclovir
1.2.5 Others
1.3 Market by Application
1.3.1 Global Viral Pneumonia Treatment Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Viral Pneumonia Treatment Drugs Market Perspective (2016-2027)
2.2 Viral Pneumonia Treatment Drugs Growth Trends by Regions
2.2.1 Viral Pneumonia Treatment Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Viral Pneumonia Treatment Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Viral Pneumonia Treatment Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Viral Pneumonia Treatment Drugs Industry Dynamic
2.3.1 Viral Pneumonia Treatment Drugs Market Trends
2.3.2 Viral Pneumonia Treatment Drugs Market Drivers
2.3.3 Viral Pneumonia Treatment Drugs Market Challenges
2.3.4 Viral Pneumonia Treatment Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Viral Pneumonia Treatment Drugs Players by Revenue
3.1.1 Global Top Viral Pneumonia Treatment Drugs Players by Revenue (2016-2021)
3.1.2 Global Viral Pneumonia Treatment Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Viral Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Pneumonia Treatment Drugs Revenue
3.4 Global Viral Pneumonia Treatment Drugs Market Concentration Ratio
3.4.1 Global Viral Pneumonia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Pneumonia Treatment Drugs Revenue in 2020
3.5 Viral Pneumonia Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Viral Pneumonia Treatment Drugs Product Solution and Service
3.7 Date of Enter into Viral Pneumonia Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Pneumonia Treatment Drugs Breakdown Data by Type
4.1 Global Viral Pneumonia Treatment Drugs Historic Market Size by Type (2016-2021)
4.2 Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Type (2022-2027)

5 Viral Pneumonia Treatment Drugs Breakdown Data by Application
5.1 Global Viral Pneumonia Treatment Drugs Historic Market Size by Application (2016-2021)
5.2 Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Viral Pneumonia Treatment Drugs Market Size (2016-2027)
6.2 North America Viral Pneumonia Treatment Drugs Market Size by Type
6.2.1 North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021)
6.2.2 North America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027)
6.2.3 North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027)
6.3 North America Viral Pneumonia Treatment Drugs Market Size by Application
6.3.1 North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021)
6.3.2 North America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027)
6.3.3 North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027)
6.4 North America Viral Pneumonia Treatment Drugs Market Size by Country
6.4.1 North America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021)
6.4.2 North America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Viral Pneumonia Treatment Drugs Market Size (2016-2027)
7.2 Europe Viral Pneumonia Treatment Drugs Market Size by Type
7.2.1 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021)
7.2.2 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027)
7.2.3 Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027)
7.3 Europe Viral Pneumonia Treatment Drugs Market Size by Application
7.3.1 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021)
7.3.2 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027)
7.3.3 Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027)
7.4 Europe Viral Pneumonia Treatment Drugs Market Size by Country
7.4.1 Europe Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021)
7.4.2 Europe Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size (2016-2027)
8.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type
8.2.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application
8.3.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region
8.4.1 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Viral Pneumonia Treatment Drugs Market Size (2016-2027)
9.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Type
9.2.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027)
9.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Application
9.3.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027)
9.4 Latin America Viral Pneumonia Treatment Drugs Market Size by Country
9.4.1 Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size (2016-2027)
10.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type
10.2.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application
10.3.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country
10.4.1 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Viral Pneumonia Treatment Drugs Introduction
11.1.4 Roche Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.1.5 Roche Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Viral Pneumonia Treatment Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Viral Pneumonia Treatment Drugs Introduction
11.3.4 Pfizer Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Viral Pneumonia Treatment Drugs Introduction
11.4.4 Novartis Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Details
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Viral Pneumonia Treatment Drugs Introduction
11.5.4 Johnson and Johnson Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.5.5 Johnson and Johnson Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Viral Pneumonia Treatment Drugs Introduction
11.6.4 Teva Pharmaceutical Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021)
11.6.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Viral Pneumonia Treatment Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ribavirin
Table 3. Key Players of Acyclovir
Table 4. Key Players of Ganciclovir
Table 5. Key Players of Others
Table 6. Global Viral Pneumonia Treatment Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Viral Pneumonia Treatment Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Viral Pneumonia Treatment Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2016-2021)
Table 10. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2022-2027)
Table 12. Viral Pneumonia Treatment Drugs Market Trends
Table 13. Viral Pneumonia Treatment Drugs Market Drivers
Table 14. Viral Pneumonia Treatment Drugs Market Challenges
Table 15. Viral Pneumonia Treatment Drugs Market Restraints
Table 16. Global Viral Pneumonia Treatment Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Viral Pneumonia Treatment Drugs Market Share by Players (2016-2021)
Table 18. Global Top Viral Pneumonia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Pneumonia Treatment Drugs as of 2020)
Table 19. Ranking of Global Top Viral Pneumonia Treatment Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Viral Pneumonia Treatment Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Viral Pneumonia Treatment Drugs Product Solution and Service
Table 23. Date of Enter into Viral Pneumonia Treatment Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Viral Pneumonia Treatment Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Viral Pneumonia Treatment Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Viral Pneumonia Treatment Drugs Product
Table 66. Roche Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. GlaxoSmithKline Company Details
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Viral Pneumonia Treatment Drugs Product
Table 71. GlaxoSmithKline Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Viral Pneumonia Treatment Drugs Product
Table 76. Pfizer Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Viral Pneumonia Treatment Drugs Product
Table 81. Novartis Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Johnson and Johnson Company Details
Table 84. Johnson and Johnson Business Overview
Table 85. Johnson and Johnson Viral Pneumonia Treatment Drugs Product
Table 86. Johnson and Johnson Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 87. Johnson and Johnson Recent Development
Table 88. Teva Pharmaceutical Company Details
Table 89. Teva Pharmaceutical Business Overview
Table 90. Teva Pharmaceutical Viral Pneumonia Treatment Drugs Product
Table 91. Teva Pharmaceutical Revenue in Viral Pneumonia Treatment Drugs Business (2016-2021) & (US$ Million)
Table 92. Teva Pharmaceutical Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Pneumonia Treatment Drugs Market Share by Type: 2020 VS 2027
Figure 2. Ribavirin Features
Figure 3. Acyclovir Features
Figure 4. Ganciclovir Features
Figure 5. Others Features
Figure 6. Global Viral Pneumonia Treatment Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Viral Pneumonia Treatment Drugs Report Years Considered
Figure 12. Global Viral Pneumonia Treatment Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Viral Pneumonia Treatment Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Viral Pneumonia Treatment Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Viral Pneumonia Treatment Drugs Market Share by Regions (2022-2027)
Figure 16. Global Viral Pneumonia Treatment Drugs Market Share by Players in 2020
Figure 17. Global Top Viral Pneumonia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Pneumonia Treatment Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Viral Pneumonia Treatment Drugs Revenue in 2020
Figure 19. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Viral Pneumonia Treatment Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027)
Figure 23. North America Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027)
Figure 24. North America Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027)
Figure 25. United States Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027)
Figure 29. Europe Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027)
Figure 30. Europe Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027)
Figure 31. Germany Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Viral Pneumonia Treatment Drugs Market Share by Region (2016-2027)
Figure 41. China Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Viral Pneumonia Treatment Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Viral Pneumonia Treatment Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 64. Johnson and Johnson Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 65. Teva Pharmaceutical Revenue Growth Rate in Viral Pneumonia Treatment Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---